Anyone who has had COVID-19—even if it was a mild case—is at a higher risk of developing blood clots for months after recovery. If untreated, blood clot complications such as deep vein thrombosis and pulmonary embolism can cause serious damage to the heart or lungs. A new study found that full-dose blood-thinning medications might help reduce the risk of blood clots in critically ill COVID-19 patients. Typically, hospitalized COVID-19 patients might be given a relatively low dose of blood thinner to prevent blood clots, as a high dose might lead to severe bleeding. The study showed that a full-dose blood thinner did increase bleeding, but it didn’t increase the risk of death. Ankit Shah, MD, an assistant professor at Rutgers New Jersey Medical School, told Verywell that the risk of life-threatening blood clots from COVID-19 appears to be lower now with more advanced treatment and milder variants. To read the full story.